ImpediMed

Examine the segmental sample report to see how SOZO delivers comprehensive analysis for monitoring segmental body composition and managing patient health.

Understand the reference ranges for body composition analysis with SOZO, essential for accurate interpretation and patient assessment.

View sample reports from SOZO’s body composition analysis, showcasing the detailed insights available for healthcare providers and patients.

The L-Dex bilateral report analyzes both limbs to support comprehensive lymphedema monitoring.

This webinar discusses how bioimpedance spectroscopy and body composition assessments can improve lymphedema surveillance and NAPBC compliance.

Bioimpedance spectroscopy (BIS) helps inform athlete recovery, hydration, and return-to-play decisions in sports medicine.

GLP-1 weight-loss drugs may cause cancer patients to lose up to 40% of their muscle, not fat, making muscle preservation key in cancer care.

A webinar with Dr. Nicole Stout explains how a surveillance model can help breast cancer centers meet three 2027 NAPBC standards.

Meet Blake Ahitow, bringing nearly 20 years of MedTech leadership experience in sales, commercial strategy, IDN partnerships, and patient outcomes.

ImpediMed’s steady growth and success is the result of an experienced, visionary leadership team comprised of seasoned executives and board members, including Erik Johnson.

Gina Kimball, Head of Commercial Operations at ImpediMed, brings 20+ years of experience driving commercial strategy, growth, and business transformation.

Richelle Gaw, PhD, is Director of Research Science & Medical Affairs at ImpediMed, leading bioimpedance spectroscopy research and clinical validation.

ImpediMed’s bioimpedance spectroscopy (BIS) devices accurately and noninvasively aid for early detection, assessment, and intervention in chronic diseases.